RESEARCH TRIANGLE PARK, N.C., Dec. 11 /CNW/ -- Quintiles Transnational
Corp. today announced the appointment of John Goodacre as Executive Vice
President and General Counsel.
Previously Senior Vice President, Global Risk Management and Quality
Assurance, Goodacre joined Quintiles in 1998 as Vice President, European Legal
"John has a thorough understanding of Quintiles and the clinical research
industry, having served the company in various capacities over the past 20
years - including as outside counsel when we formed Quintiles (UK) Limited,
our first international subsidiary, in 1987," said Dennis Gillings, CBE,
Chairman and Chief Executive Officer of Quintiles Transnational. "With his
strong legal background and experience in leading our risk management and QA
group, John will help Quintiles continue to grow and protect our interests."
In his new role, Goodacre is responsible for Quintiles' global legal
function and risk management; he also joins the Quintiles Transnational
Executive Committee. He reports to Mike Mortimer, Executive Vice President and
Chief Administrative Officer.
Prior to joining Quintiles, Goodacre spent more than 20 years practicing
law as a partner in law firms in central London. He holds two degrees from
Quintiles Transnational Corp. is powering the next generation of
healthcare by providing a broad range of professional services in drug
development, financial partnering and commercialization for the
pharmaceutical, biotechnology and healthcare industries. With about 20,000
employees and offices in more than 50 countries, it is focused on providing
customer-centric solutions that are the gold standard of the industry. For
more information, please visit the company's Web site at www.qtrn.com.
For further information:
For further information: Jay Johnson, Media Relations, +1-919-998-2091,
email@example.com, or Greg Connors, Investor Relations,
+1-919-998-2000, firstname.lastname@example.org, both of Quintiles Transnational Corp.